Urinary liver-type fatty acid-binding protein is associated with subendocardial viability ratio in middle- and older-aged adults

被引:3
作者
Kosaki, Keisei [1 ]
Kamijo-Ikemori, Atsuko [2 ,3 ]
Sugaya, Takeshi [2 ,4 ]
Tanahashi, Koichiro [1 ]
Kumagai, Hiroshi [5 ]
Sawano, Yuriko [1 ]
Akazawa, Nobuhiko [5 ]
Osuka, Yosuke [6 ]
Tanaka, Kiyoji [5 ]
Kimura, Kenjiro [7 ]
Shibagaki, Yugo [2 ]
Maeda, Seiji [5 ]
机构
[1] Univ Tsukuba, Grad Sch Comprehens Human Sci, Ibaraki, Japan
[2] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan
[3] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan
[4] CMIC Co Ltd, Tokyo, Japan
[5] Univ Tsukuba, Fac Hlth & Sport Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058574, Japan
[6] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan
[7] JCHO Tokyo Takanawa Hosp, Tokyo, Japan
关键词
Cardiovascular disease; intra-renal microcirculation; myocardial perfusion; pulse wave analysis; tubular biomarker; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTORS; RENAL-FUNCTION; AGING KIDNEY; RISK-FACTORS; ALBUMINURIA; PRESSURE; MICROALBUMINURIA; MORTALITY;
D O I
10.1080/10641963.2017.1356845
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: To identify one of the physiological underlying mechanisms of the predictive effects of urinary liver-type fatty acid-binding protein (L-FABP) for the onset of cardiovascular disease (CVD), we investigated the relationship between urinary L-FABP levels and subendocardial viability ratio (SEVR), a marker of myocardial perfusion, in middle- and older-aged adults.Methods: This was a cross-sectional study of 249 middle- and older-aged adults (aged 46-83years). We measured urinary L-FABP levels and central hemodynamic parameters, including SEVR, calculated by pulse wave analysis using an applanation tonometry.Results: In the participants stratified in accordance with the tertiles of urinary L-FABP levels, SEVR decreased in a stepwise fashion with increasing tertiles (p<0.001). Furthermore, this association remains significant after the consideration of various confounders. On the contrary, urinary albumin levels were not independently related with SEVR.Conclusion: Our results demonstrated that urinary L-FABP levels were independently associated with the SEVR of the middle- and older-aged adults. This result suggests that the increase in urinary L-FABP levels even within the normal range might be related to the decrease in myocardial perfusion (SEVR).
引用
收藏
页码:244 / 250
页数:7
相关论文
共 50 条
  • [31] Elevation of urinary liver-type fatty acid binding protein after cardiac catheterization related to cardiovascular events
    Kamijo-Ikemori, Atsuko
    Hashimoto, Nobuyuki
    Sugaya, Takeshi
    Matsui, Katsuomi
    Hisamichi, Mikako
    Shibagaki, Yugo
    Miyake, Fumihiko
    Kimura, Kenjiro
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2015, 8 : 91 - 99
  • [32] Tissue expression and urinary excretion of liver-type fatty acid binding protein in older dogs with or without early signs of chronic kidney disease
    Marynissen, Sofie
    Demeyere, Kristel
    Daminet, Sylvie
    Meyer, Evelyne
    Chiers, Koen
    Paepe, Dominique
    VETERINARY PATHOLOGY, 2025,
  • [33] Decreased levels of urinary liver-type fatty acid-binding protein after switching from tenofovir disoproxil fumarate to tenofovir alafenamide: a prospective observational study
    Hikasa, Shinichi
    Shimabukuro, Shota
    Hideta, Kyoko
    Nishida, Sakurako
    Higasa, Satoshi
    Sawada, Akihiro
    Tokugawa, Tazuko
    Tanaka, Kuniyoshi
    Yanai, Mina
    Kimura, Takeshi
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (13) : 1311 - 1317
  • [34] Plasma Free Fatty Acids, Fatty Acid-Binding Protein 4, and Mortality in Older Adults in the Cardiovascular Health Study
    Miedema, Michael D.
    Maziarz, Marlena
    Biggs, Mary Lou
    Zieman, Susan J.
    Kizer, Jorge R.
    Ix, Joachim H.
    Mozaffarian, Dariush
    Tracy, Russell
    Psaty, Bruce M.
    Siscovick, David
    Mukamal, Kenneth J.
    Djousse, Luc
    CIRCULATION, 2013, 128 (22)
  • [35] Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention
    Yoshihara, Fumiki
    Hosoda, Hiroshi
    Doi, Takahito
    Yoshida, Morikatsu
    Kitamura, Kazuo
    Yamamoto, Haruko
    Asaumi, Yasuhide
    Ishibashi-Ueda, Hatsue
    Kishida, Masatsugu
    Arisato, Tetsuya
    Matsuo, Miki
    Miyazato, Mikiya
    Yasuda, Satoshi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2021, 25 (12) : 1319 - 1328
  • [36] Urinary liver-type fatty acid-binding protein levels as a potential risk factor for renal dysfunction in male HIV-infected Japanese patients receiving antiretroviral therapy: a pilot study
    Hikasa, Shinichi
    Shimabukuro, Shota
    Hideta, Kyoko
    Higasa, Satoshi
    Sawada, Akihiro
    Tokugawa, Tazuko
    Tanaka, Kuniyoshi
    Yanai, Mina
    Kimura, Takeshi
    INTERNATIONAL JOURNAL OF STD & AIDS, 2018, 29 (14) : 1424 - 1431
  • [37] Cross-Sectional and Longitudinal Associations between Skin Autofluorescence and Tubular Injury Defined by Urinary Excretion of Liver-Type Fatty Acid-Binding Protein in People with Type 2 Diabetes
    Yamagami, Hiroki
    Hara, Tomoyo
    Yasui, Saya
    Hosoki, Minae
    Hori, Taiki
    Kaneko, Yousuke
    Mitsui, Yukari
    Kurahashi, Kiyoe
    Harada, Takeshi
    Yoshida, Sumiko
    Nakamura, Shingen
    Otoda, Toshiki
    Yuasa, Tomoyuki
    Kuroda, Akio
    Endo, Itsuro
    Matsuhisa, Munehide
    Abe, Masahiro
    Aihara, Ken-ichi
    BIOMEDICINES, 2023, 11 (11)
  • [38] Urinary Liver-Type Fatty Acid Binding Protein, a Biomarker for Disease Progression, Dialysis and Overall Mortality in Chronic Kidney Disease
    Mitsides, Nicos
    Mitra, Vikram
    Saha, Ananya
    Harris, Shelly
    Kalra, Philip A.
    Mitra, Sandip
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (10):
  • [39] Urinary liver type fatty acid binding protein in diabetic nephropathy
    Kamijo-Ikemori, Atsuko
    Sugaya, Takeshi
    Ichikawa, Daisuke
    Hoshino, Seiko
    Matsui, Katsuomi
    Yokoyama, Takeshi
    Yasuda, Takashi
    Hirata, Kazuaki
    Kimura, Kenjiro
    CLINICA CHIMICA ACTA, 2013, 424 : 104 - 108
  • [40] L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease
    Abe, Masanori
    Maruyama, Noriaki
    Suzuki, Hiroko
    Inoshita, Atsushi
    Yoshida, Yoshinori
    Okada, Kazuyoshi
    Soma, Masayoshi
    HEART AND VESSELS, 2013, 28 (04) : 480 - 489